Patent US3901876A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3901876A Expired / Lapsed US ⏱️ 0.0 years remaining

Adenosine derivatives

Assignee: Bayer Pharma AG
•
Filing: 1972-09-14
•
Granted: 1975-08-26
•
Expires: 1992-09-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Adenosine derivatives of the formula WHEREIN A is saturated or unsaturated, straight-chain, branched or cyclic alkylene optionally substituted by one of hydroxy, acyloxy, carboxy or acyl; X is a valence bond, oxygen, sulfur, or an alkylated or acylated imino group; and B is 3-indolyl or 4imidazolyl optionally substituted by one or more of halogen, alkyl, haloalkyl, alkoxy, aryloxy, acyloxy, hydroxy, mercapto, alkylmercapto, nitro, carboxy, carboxyalkyl, or methylsulfonylamino, and processes for their preparation and use. These adenosine derivatives exert pharmacological effects on the central nervous system, the circulation, and the heart.

Inventors

  • 👤 Helmut Vorbruggen
  • 👤 Rudolf Kopp
  • 👤 Reinhard Horowski
  • 👤 Gert Paschelke
  • 👤 Dieter Palenschat

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 13:11
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/16

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 5 words
ADENOSINE DERIVATIVES OF THE FORMULA
Claim 2
Dependent Claim 5 words
ADENOSINE DERIVATIVES OF THE FORMULA
Claim 3
Dependent Claim 16 words
A compound according to claim 1, wherein A is linear saturated alkylene of 1-8 carbon atoms.
Claim 4
Dependent Claim 12 words
A compound according to claim 1, wherein X is a valence bond.
Claim 5
Dependent Claim 23 words
A compound according to claim 1, wherein B is unsubstituted indolyl or indolyl substituted at one or both of the 2- and 5-positions.
Claim 6
Dependent Claim 15 words
A compound according to claim 4, wherein B is substituted by hydroxy or lower alkoxy.
Claim 7
Dependent Claim 12 words
A compound according to claiM 4, wherein X is a valence bond.
Claim 8
Dependent Claim 16 words
A compound according to claim 4, wherein A is linear saturated alkylene of 1-8 carbon atoms.
Claim 9
Dependent Claim 23 words
A compound according to claim 1, wherein B is unsubstituted imidazolyl or imidazolyl substituted at one or both of the 1- and 5-positions.
Claim 10
Dependent Claim 15 words
A compound according to claim 8, wherein B is substituted by hydroxy or lower alkoxy.
Claim 11
Dependent Claim 12 words
A compound according to claim 8, wherein X is a valence bond.
Claim 12
Dependent Claim 16 words
A compound according to claim 8, wherein A is linear saturated alkylene of 1-8 carbon atoms.
Claim 13
Dependent Claim 9 words
A compound of claim 1, N6-( Beta -indolyl-3-ethyl) adenosine.
Claim 14
Dependent Claim 9 words
A compound of claim 1, N6-( Beta -(5-hydroxyindolyl-3)-ethyl) adenosine.
Claim 15
Dependent Claim 9 words
A compound of claim 1, N6-( Beta -(5-methoxyindolyl-3)-ethyl) adenosine.
Claim 16
Dependent Claim 9 words
A compound of claim 1, N6-( Beta -imidazolyl-4-ethyl) adenosine.

References Cited (Backward Citations)

US3269917A Cited
US3498970A Cited
US3590029A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-08-25 1979-02-24 1979-08-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-08-25 1983-02-24 1983-08-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-08-25 1987-02-24 1987-08-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag